Wednesday, September 28, 2011

Pacific Gold Corp.-Share Buyback Program

Pacific Gold Corp. (OTCQB: PCFG)(PINK SHEETS: PCFG)




Pacific Gold Corp. ("PCFG") today announced that its Board of Directors has approved a share repurchase program, effective immediately.



Under the program, PCFG is authorized to repurchase up to 5 million of its issued and outstanding common shares in the open market or in negotiated transactions, from time to time, depending on market conditions and other factors as well as subject to relevant rules under Untied States securities regulations. It does not obligate the company to make any purchases, including at any specific time or in any particular situation. The program may be suspended or discontinued at any time. The share repurchase program will be funded by the company's available cash, after assessing for the working capital requirements of the company.



"We believe it is prudent to use a portion of our future cash flow to repurchase shares. The share repurchase along with a continued commitment to developing our mining projects are planned to enhance shareholder value." said Mitch Geisler, COO of PCFG.



As of September 28, 2011, PCFG had 745,732,651 shares outstanding.



To find out more about Pacific Gold Corp. (OTCQB: PCFG)(PINK SHEETS: PCFG), visit the Company's website at www.pacificgoldcorp.com.



About the Company



Pacific Gold Corp.'s business plan provides for the acquisition and development of production-ready and in-production mining operations. The company is focused on alluvial gold and base metals operations located in western North America. Pacific Gold Corp. owns four operating subsidiaries: Nevada Rae Gold, Inc., which owns and operates the Black Rock Canyon gold mine, located in north-central Nevada; Pilot Mountain Resources Inc., which owns Project W, a large tungsten based deposit in Nevada; Fernley Gold, Inc., which has acquired exclusive lease rights to mine the Lower Olinghouse Placers in north-western Nevada; and Pacific Metals Corp., which owns claims in San Juan and Delores Counties, Colorado, encompassing the historic Graysill Mine.



This news release includes forward-looking statements that reflect Pacific Gold Corp.'s current expectations about its future results, performance, prospects and opportunities. Pacific Gold Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward- looking statements are based on information currently available to Pacific Gold Corp. and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities in the remainder of 2011 and beyond, to differ materially from those expressed in, or implied by, these forward-looking statements.



Contacts:



Pacific Gold Corp.



416-214-1483



www.pacificgoldcorp.com









Tuesday, September 27, 2011

Compass Biotech

Compass Biotechnologies (COBI:OB) is a product-oriented specialty biotechnology company focused on offering products for multi-billion dollar markets. The company is pleased to announce it has entered into an expanded relationship with PanGen Biotech of South Korea, which will allow Compass to offer a globally marketed comprehensive laboratory reagents product line for sale under the Compass Biotech name. The worldwide laboratory reagents market was estimated to be worth $13.7bn in 2010 and is part of the overall Life Science/In Vitro Diagnostics market currently worth globally $45 Billion per year.




Compass Biotech will initially prepare to offer lab reagents known as cytokines along with various cell growth factors. From SEC filings of leading companies in the cytokine and growth factor area, it is estimated these lab products represent an estimated $350 million market in the EU and USA which has been growing steadily in the 15% range over the last 5 years.



Cytokine and growth factor related revenues account for 20% of the total world biopharma revenues or $80-100 billion. Approximately 50% of growth factor revenues are derived from development of recombinant protein therapies, $15 billion for vaccines, $10 billion for plasma-derived proteins and another $5 billion for biosimiliar forms of existing therapeutic products.



"With Compass focused on developing protein therapeutics, biosimiliar and vaccine products, we felt being able to also offer these important laboratory reagents on a worldwide basis would allow a congruence of our expertise and knowledge base, while allowing us access to faster and nearer term revenue from sales of these reagents and cell culture media supplements" commented Compass CEO Garth Likes. He further stated, "With PanGen as a partner, we will be able to offer these products at very attractive and competitive price points".



Dr. Jaeseung Yoon, founder and CEO of PanGen noted, "our relationship with Compass is growing, and their expertise in product development outside of our target market areas makes great sense for expanding the markets for PanGen products and technology."



ABOUT COMPASS BIOTECHNOLOGIES INC. www.compassbio.net



Compass Biotechnologies is a publically-traded specialty biopharmaceutical company (COBI:OB) with headquarters in Edmonton, Alberta. The mission of Compass is to develop new and exciting recombinant biosimiliar and bio-better drug products that can bring revenue generation to the company in a near term fashion with a significant longer-term upside potential. The Company has also entered into the laboratory research reagents market by initially offering cytokine and cell growth research products. Furthermore, Compass owns an exclusive worldwide license from the National Institutes of Health (NIH) and has opportunities to develop products from the vaccine and immunotherapy platform technology or sub-licensees and other interested partners. Compass Biotech also owns a subsidiary company called C-Pharma, Inc.



ABOUT C-PHARMA, INC.



C-Pharma's technology encompasses the use of recombinant DNA technology to manufacture virus-like particles (VLPs). These VLPs can be engineered to incorporate various viral and non-viral antigens for use as vaccines against many different types of targets such as hepatitis C. The recombinant antigens presented in the context of a VLP carrier system are much more immunogenic than the antigen alone, and this carrier is so powerful that the subsequent vaccine may not require the use of an immune adjuvant. C-Pharma is using the technology to develop a hepatitis C vaccine to prevent hepatitis C viral infection. The Company is also pursuing a revenue generation strategy by commercializing generic ribavirin and pegylated alpha interferon, the standard-of-care therapeutic drugs for use in the hepatitis C and hepatitis B markets.



ABOUT PANGEN BIOTECH INC.



PanGen is a leading biotechnology company based in South Korea in developing animal cell lines (particularly Chinese Hamster Ovary cells) and in production of proteins or antibodies from those cells. PanGen has developed novel CHO cell expression systems that confer the overall efficiency of manipulation to cut down the conventional time and costs to handle the recombinant gene expression in animal cells. The combination of the patent pending technologies and well-trained researchers has made PanGen one of the leading companies in CHO cell technology. PanGen produces proteins or cell lines for industry, academic, and governmental organizations for use in high-throughput screening, in vivo studies, diagnostics, research reagents, and the therapeutic purposes. The company's new manufacturing facility will provide the capacity to manufacture products for Compass and other clients on a contract manufacturing basis.



Forward Looking Statements



This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this current report which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainty of financial estimates and projections, the competitive and regulatory environments, stock market conditions, unforeseen technical difficulties and our ongoing ability to operate a business and obtain financing. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that our beliefs, plans, expectations and intentions contained in this current report are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our quarterly reports on Form 10-Q and our other periodic reports filed from time-to-time with the Securities and Exchange Commission pursuant to the Securities Exchange Act.



SOURCE Compass Biotechnologies Inc.



Thursday, September 22, 2011

Atlas Capital Holdings Inc. (OTCQB: ALCL)

Atlas Capital Holdings Inc. (OTCQB: ALCL) (OTCBB: ALCL) (the "Company") today announced that its wholly owned subsidiary, AlgaeTek Systems, Inc. (AlgaeTek Systems), will commence development of its new algae Pilot Program in the acclaimed Houston Advanced Research Center located in Woodlands, TX. The management of Atlas Capital Holdings will be touring the facility this week.




"We are excited to be visiting the Houston Advanced Research Center to review the progress that is being made on the development of our new algae Pilot Facility. We expect the technologies and experience of operating this Facility to translate into an expanded facility capable of launching our company into the large scale production and commercialization of high quality algae for the market," stated Christopher Davies, CEO of Atlas Capital Holdings, Inc.



The Houston Advanced Research Center uses the tools of science, policy and technology to provide new knowledge about the complex balance between environmental, social and economic issues in our region. Program areas include clean energy, air quality and climate and land, water and people.



About Atlas Capital Holdings, Inc.



Atlas Capital Holdings, Inc. was incorporated in the State of Nevada on September 13, 2006. The Company was formerly known as Micro Mammoth Solutions, Inc. and operated as such until January 25, 2010. On January 26, 2010, the Board of Directors of the Company approved a Stock Purchase Agreement between the Company and all of the shareholders of Atlas Capital Partners, LLC. Following the acquisition of Atlas Capital Partners the shareholders approved an amendment to the Company's Articles of Incorporation changing the Company's name from Micro Mammoth Solutions, Inc. to Atlas Capital Holdings, Inc.



Forward Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Atlas Capital Holdings, Inc. undertakes no obligation to update such statements.



CONTACT:



Atlas Capital Holdings, Inc.



Christopher Davies



561-488-7623





Monday, September 19, 2011

Landis Lifestyle Salons' Staff Assist at New York Fashion Week

 Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE), a majority owned subsidiary of Nexia Holdings, Inc. (PINKSHEETS: NXHD), announced today that its staff including Logan Fast and Kristian Bankston were backstage at this year's New York Fashion week working side by side with some of the top stylists and make-up artists in the world.




This year was Logan Fast's third year at NYC Fashion Week. Logan is an Aveda Purefessional, the education director at Landis Lifestyle Salons and Vice President of Green Endeavors, Inc. Kristian Bankston is a long standing team member of Landis who has worked her way from a front desk staff member to a top producing stylist over the last 5 years.



Richard Surber, CEO, commented, "I am proud to have these two members of our staff in effect representing Aveda and Landis Salons at one of the world's most prestigious fashion events. Being invited to work New York Fashion week is a great way to network and meet top talent in the world of beauty and fashion. Only a few elite people in the salon industry have the privilege to work with people like Antoinette Beenders, Aveda's Global Creative Director." Here is a video of the Aveda team backstage with Christian Siriano: http://youtu.be/51R6PPgOrA8.



Along the same lines, Landis' staff of nearly 50 stylists show their passion for their craft everyday in our salons. Recently, Landis won Best Salon in the state of Utah (see www.bestofstate.org) and Best Hair Design (see www.CityWeekly.net).



Wednesday, September 14, 2011

GRNE Key to Future Salon Growth and Recent Developments

GRNE(0.0052)nice NEWS out>> Green Endeavors' CEO, Richard Surber, Discusses Key to Future Salon Growth and Recent Developments




Today : Wednesday 14 September 2011



Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE) is a majority-owned subsidiary of Nexia Holdings, Inc. (PINKSHEETS: NXHD). Mr. Richard Surber, CEO of Green, stated his belief, "The key to future growth is fully developing a staff with a single minded focus on excellent guest services." To that end Landis Salons is proud to announce that under the direction of Logan Fast, Vice President of Green and Landis' lead educator, our salons recently promoted 8 stylists from our New Artist training program to Grand Salon Stylist. In addition, we expect to promote an additional two stylists prior to the end of September. The salons are now conducting group interviews on a regular basis. The most recent interview process will lead to auditioning 6 additional stylists in the coming week. Prior to the holiday season, an additional 4 new hires should be working in the salons.







The plan is to begin staffing for our future locations by training stylists in our current facilities. One factor that will greatly speed the process up will be the Aveda™ Institute in Provo, Utah; which will soon be graduating a substantial number of Aveda™ trained stylists. A single stylist that masters the art of excellent guest service can generate in excess of $80,000 in revenues over the course of 12 months. Kassie Hill, Landis' Regional Salon Manager, noted, "We are excited to have the opportunity to hire graduates with extensive Aveda™ training through the Institute. The education Aveda™ offers a stylist gives both Landis and the stylist an added advantage within the industry."



In addition to opening more full service salons that offer a full range of Aveda™ products, another opportunity to enhance our operations include potentially opening an Aveda™ Experience center in the City Creek development in the heart of downtown Salt Lake City. City Creek is being developed by Taubman Company, a premier mall operator and developer. Discussions are ongoing with regard to such a retail store. City Creek is scheduled for opening in March of 2012.



About Green Endeavors, Inc.:



Green Endeavors, Inc. (OTCQB: GRNE), headquartered in Salt Lake City, Utah, is a holding company with operations in health & beauty. GRNE's wholly owned subsidiaries, Landis Salons, Inc., and Landis Salons II, Inc., http://www.landissalons.com, are hair salons built around the world-class AVEDA™ product line. For more information, visit http://www.green-endeavors.com.



GRNE strongly encourages the public to read the above information in conjunction with its filings and disclosures filed in 2010 and 2011. GRNE's disclosures can be viewed at www.sec.gov and www.otcmarkets.com. Investors should not invest more than they can afford to lose in penny stocks. Green Endeavors is a subsidiary of Nexia Holdings, Inc., headquartered in Salt Lake City, Utah. Nexia is a diversified holdings company with operations in entertainment, health & beauty, and real estate. You can find out more at Green Endeavors Facebook and Landis Salons Facebook, More information can be found by visiting www.nexiaholdings.com, Nexia Holdings' Facebook, Multivu Link, or visit The Kane Files Facebook.



FOR MORE INFORMATION, CONTACT:

GRNE <>News !> Green Endeavors' CEO, Richard Surber, Discusses Key to Future Salon Growth and Recent Developments

print

Green Endeavors (QB CE) (USOTC:GRNE)

Intraday Stock Chart

Today : Wednesday 14 September 2011



Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE) is a majority-owned subsidiary of Nexia Holdings, Inc. (PINKSHEETS: NXHD). Mr. Richard Surber, CEO of Green, stated his belief, "The key to future growth is fully developing a staff with a single minded focus on excellent guest services." To that end Landis Salons is proud to announce that under the direction of Logan Fast, Vice President of Green and Landis' lead educator, our salons recently promoted 8 stylists from our New Artist training program to Grand Salon Stylist. In addition, we expect to promote an additional two stylists prior to the end of September. The salons are now conducting group interviews on a regular basis. The most recent interview process will lead to auditioning 6 additional stylists in the coming week. Prior to the holiday season, an additional 4 new hires should be working in the salons.







The plan is to begin staffing for our future locations by training stylists in our current facilities. One factor that will greatly speed the process up will be the Aveda™ Institute in Provo, Utah; which will soon be graduating a substantial number of Aveda™ trained stylists. A single stylist that masters the art of excellent guest service can generate in excess of $80,000 in revenues over the course of 12 months. Kassie Hill, Landis' Regional Salon Manager, noted, "We are excited to have the opportunity to hire graduates with extensive Aveda™ training through the Institute. The education Aveda™ offers a stylist gives both Landis and the stylist an added advantage within the industry."



In addition to opening more full service salons that offer a full range of Aveda™ products, another opportunity to enhance our operations include potentially opening an Aveda™ Experience center in the City Creek development in the heart of downtown Salt Lake City. City Creek is being developed by Taubman Company, a premier mall operator and developer. Discussions are ongoing with regard to such a retail store. City Creek is scheduled for opening in March of 2012.



About Green Endeavors, Inc.:



Green Endeavors, Inc. (OTCQB: GRNE), headquartered in Salt Lake City, Utah, is a holding company with operations in health & beauty. GRNE's wholly owned subsidiaries, Landis Salons, Inc., and Landis Salons II, Inc., http://www.landissalons.com, are hair salons built around the world-class AVEDA™ product line. For more information, visit http://www.green-endeavors.com.



GRNE strongly encourages the public to read the above information in conjunction with its filings and disclosures filed in 2010 and 2011. GRNE's disclosures can be viewed at www.sec.gov and www.otcmarkets.com. Investors should not invest more than they can afford to lose in penny stocks. Green Endeavors is a subsidiary of Nexia Holdings, Inc., headquartered in Salt Lake City, Utah. Nexia is a diversified holdings company with operations in entertainment, health & beauty, and real estate. You can find out more at Green Endeavors Facebook and Landis Salons Facebook, More information can be found by visiting www.nexiaholdings.com, Nexia Holdings' Facebook, Multivu Link, or visit The Kane Files Facebook.



FOR MORE INFORMATION, CONTACT:



Richard Surber



President



Green Endeavors, Inc.



801-575-8073 x 106



Email Contact



http://www.richardsurber.us



Richard Surber



President



Green Endeavors, Inc.



801-575-8073 x 106



Email Contact



http://www.richardsurber.us

Tuesday, September 13, 2011

GRNE's Salon Revenues Reach $255,000 for August 2011; Marmalade Store Achieves Record Sales

Green Endeavors, Inc. (OTCQB: GRNE) (PINKSHEETS: GRNE), a majority-owned subsidiary of Nexia Holdings, Inc. (PINKSHEETS: NXHD), announced today that its Landis / AVEDA™ salon operations, which are powered in part by renewable energy, posted revenues of $255,000 for the month of August 2011, a 20% increase over the same month in 2010.




Revenues were generated from two locations, Landis' flagship store located in Liberty Heights and its newest store in the Marmalade district of Salt Lake City. Combined total revenues for both locations were $254,993 (unaudited) in August 2011, compared to total revenues of $194,256 (audited) for the comparable month in 2010. The Marmalade salon reported its best month ever since opening its doors in October 2010 and the August revenue numbers continue a pattern of growth month to month.



"It is satisfying to see the continued success of our flagship store in Liberty Heights, as we reach new milestones at our Marmalade location," said Richard Surber, CEO of Nexia Holdings, Inc. and Green Endeavors, Inc. "Month after month, Landis has consistently grown sales in the double-digit range this year over last. This is a testament to the hard work and value offered by Landis employees. Landis has proven once again that it can succeed in a challenging economy, while reducing its overall impact on the environment."



About Green Endeavors, Inc.:



Green Endeavors, Inc. (OTCQB: GRNE), headquartered in Salt Lake City, Utah, is a holding company with operations in health & beauty. GRNE's wholly owned subsidiaries, Landis Salons, Inc. and Landis Salons II, Inc., http://www.landissalons.com, are hair salons built around the world-class AVEDA™ product line. For more information, visit http://www.green-endeavors.com.



GRNE strongly encourages the public to read the above information in conjunction with its filings and disclosures filed in 2010 and 2011. GRNE's disclosures can be viewed at www.sec.gov and www.otcmarkets.com. Investors should not invest more than they can afford to lose in penny stocks. Green Endeavors is a subsidiary of Nexia Holdings, Inc., headquartered in Salt Lake City, Utah. Nexia is a diversified holdings company with operations in entertainment, health & beauty, and real estate. You can find out more at Green Endeavors Facebook and Landis Salons Facebook, More information can be found by visiting www.nexiaholdings.com, Nexia Holdings' Facebook, Multivu Link, or visit The Kane Files Facebook.



FOR MORE INFORMATION, CONTACT:



Richard Surber



President



Green Endeavors, Inc.



801-575-8073 x 106



Email Contact





Thursday, September 8, 2011

El Maniel International, Inc Establishes Subsidiary in Papua New Guinea

El Maniel International Inc (Pink Sheets:EMLL) has successfully established a local subsidiary in Papua New Guinea (PNG) known as PNG Gold Resources Limited to focus on developing our gold business domain in PNG. "We are very excited about the establishment of this subsidiary in PNG and the first project undertaken by PNG Gold Resources Limited will be the alluvial gold mining project situated in Enga Province of PNG which has a projected gold reserve of 270,000 ounces with potential value of about $500 million based on current gold prices" according to Jamie Khoo, CEO of El Maniel International, Inc "In addition, PNG Gold Resources Limited is also exploring possibilities of initiating gold trading in PNG to complement and contribute synergistically to our current operations in the West Africa in effort to generate additional revenue streams to enhance shareholder's value," said Jamie Khoo.




The Bank of Papua New Guinea has the sole authority to grant gold export licenses and currently, there are only about 7 export license holders. "We have initiated efforts to secure the gold export license from the Bank of Papua New Guinea and in view that gold trading is a very lucrative multimillion dollar business in PNG, if we can secure the gold export license, we can generate tremendous revenues to increase our bottom-line profits," added Jamie Khoo.



"All our activities in PNG will be consolidated under PNG Gold Resources Limited which will be managed by experienced management team supported by a team of geologists, engineers as well as skilled and semi-skilled workers" said Jamie Khoo "We are also in discussion to acquire more alluvial gold mining projects in PNG under this Company and in view of the abundant gold resources in the Country we believe that there is strong potential for us to become a dominant player in the Australasian Region under this domain which we expect to eventually contribute at least 50% of our total revenues".



About El Maniel International, Inc:



El Maniel International Inc is a publicly traded company currently focusing in the gold business domain including but not limited to trading, prospecting, developing and expanding the economic potential of its world class mining claims and the company is committed in creating shareholder's value by ensuring constant development of current and new resources in its global gold business domain. For further information and updates, visit www.elmaniel.com

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: The statements contained in this release which are not historical facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. These risk and uncertainties include the Company's entry into new commercial businesses, the risk of obtaining financing, recruiting and retaining qualified personnel, and other risks described in the Company's Securities and Exchange Commission filings. The forward-looking statements in this press release speak only as of the date hereof, and the Company disclaims any obligation to provide updates, revisions or amendments to any forward-looking statement to reflect changes in the Company's expectations or future events.



CONTACT: Investor Relations

El Maniel International, Inc

(212) 726-2179

ir@elmaniel.com